car-t cell trial safety
Disqualify Your Way Into Better CAR-T Therapy Safety
In 2024, the CASTLE basket trial began enrolling patients with refractory autoimmune disease. The most powerful safeguard was not a drug but the rigorous set of disqualification rules that filtered out the highest-risk applicants. Those rejection letters reveal the real-world safety net built into the study. Medical Disclaimer: This article